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ZebraﬁshSpleen tyrosine kinase (Syk) plays critical roles in B-cell and T-cell development, the maintenance of vascular
integrity, and proper partitioning of the blood vascular and lymphatic vascular system. Here, we utilize the
zebraﬁsh as an in vivo system to demonstrate novel roles for Syk and the related kinase Zeta associated
protein (Zap-70) in promoting angioblast migration. Partial knockdown of either gene results in early
angiogenic delay of the intersegmental vessels, dorsal intersegmental vessel patterning defects, and partial
loss of the thoracic duct. Higher dose knockdown of both genes results in little to no angiogenic sprouting of
the intersegmental vessels, a phenotype which resembles knockdown of vegfa. Di-phosphorylated ERK, an
effector of the vegfa pathway, is also downregulated in the aorta of syk:zap double morphants. Over-
expression of syk under the control of a blood-speciﬁc or vascular-speciﬁc promoter rescues sprouting
defects after loss of vegfa. Together these results suggest that syk and zap-70 function redundantly in an
early progenitor to promote the migration of intersegmental vessel angioblasts and lymphangioblasts that
contribute to the thoracic duct, either downstream of, or in parallel to vegfa.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Regulation of vascular sprouting and growth involves multiple
overlapping molecular pathways, and is still incompletely under-
stood. Spleen tyrosine kinase (Syk) is a cytosolic kinase important for
vascular, lymphatic, B-cell, and T-cell development (Abtahian et al.,
2003; Cheng et al., 1995; Cornall et al., 2000; Sebzda et al., 2006;
Turner et al., 1995; Yanagi et al., 2001). Syk is also critical for vascular
development as most null mice die shortly after birth with systemic
hemorrhage and edema (Cheng et al., 1995; Turner et al., 1995) due to
improper partitioning of the developing lymphatic system from the
blood vascular system, resulting in blood-ﬁlled lymphatics (Abtahian
et al., 2003; Sebzda et al., 2006). Slp-76 serves as a substrate for Syk,
and null mice display a similar phenotype but also develop a network
of dilated and tortuous blood vessels in the small intestine suggesting
a role in vascular patterning and migration (Abtahian et al., 2003). In
cell culture, Syk is involved in endothelial-cell proliferation and
migration (Inatome et al., 2001), while lymphatic defects in Syk null
embryos result from loss of signaling in circulating endothelial
precursor cells (EPCs), which contribute to the developing lymphatic
vasculature (Sebzda et al., 2006).
Zeta associated protein 70 (Zap-70) is a cytosolic tyrosine kinase,
structurally related to Syk, that functions in hematopoietic activation
and differentiation by signaling through T-cell antigen receptors
(Arpaia et al., 1994). ZAP-70 deﬁciency in humans results in severecompromised immune deﬁciency syndrome due to the loss of sig-
naling in T-cells (Arpaia et al., 1994; Chan et al., 1994; Elder et al.,
1995; Elder et al., 1994; Gelfand et al., 1995). Although related in
structure and function (as syk and zap-70 are functionally inter-
changeable (Fallah-Arani et al., 2008; Gong et al., 1997)) lymphatic or
blood endothelial defects have not been detected after loss of zap-70.
In B- and T-lymphocytes, Syk and Zap-70 bind to an ‘immunor-
eceptor tyrosine-based activation’ motif (ITAM) consisting of a con-
sensus sequencewith two tyrosines about 10–12 amino acids apart on
immune receptors (Turner et al., 2000). Upon receptor activation
these tyrosines become phosphorylated allowing cytoplasmic tyro-
sine kinases, including Syk and Zap-70, to bind the phosphorylated
ITAM motifs through their SH2 domains and initiate downstream
signaling. In vitro, Syk and Zap-70 have been shown to activate PLCγ1
(Law et al., 1996; Williams et al., 1999) and ERK (Grifﬁth et al., 1998;
Parsa et al., 2008; Shan et al., 2001; Slack et al., 2007). PLCγ1 and ERK
are also important downstream components of the vegfa pathway in
endothelial cells, and are involved in angiogenesis (Hong et al., 2006;
Lawson et al., 2003). However, it is not known whether Syk or Zap-70
functions in endothelial cells in vivo, and if they function through
similar pathways in endothelial cells as they do in B-cells and T-cells.
The external fertilization, optical clarity and availability of ﬂuores-
cent transgenic animals make zebraﬁsh an excellent model system for
many developmental studies. The recent discovery of a functional
lymphatic system in zebraﬁsh has opened the door to take advantage
of the unique beneﬁts of zebraﬁsh genetics and development to
decipher the molecules and processes involved in blood–lymphatic
vascular separation in vivo (Hogan et al., 2009; Kuchler et al.,
2006; Yaniv et al., 2006). Although many of the genes involved in
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mals and zebraﬁsh, the lymphatic vasculature of zebraﬁsh develops by
an alternative mechanism (Kuchler et al., 2006; Yaniv et al., 2006). In
mammals, lymphatic endothelial cells bud off from the main cardinal
vein and migrate to form the primary lymphatics (Wigle et al., 2002;
Wigle and Oliver, 1999).While zebraﬁsh lymphatics are still venous in
origin, individual angioblasts do not directly pinch off from the major
vein. Instead, they initially migrate as individual cells to the horizontal
myoseptum before migrating dorsally to contribute to the dorsal
longitudinal lymphatic vessels, or ventrally to contribute to the main
thoracic duct (Hogan et al., 2009; Yaniv et al., 2006). This novel
mechanism of zebraﬁsh lymphatic development prompted us to
analyze the function of zebraﬁsh syk and zap-70 in the developing
vasculature to see if they play similar roles in ﬁsh angiogenesis
and lymphangiogenesis as they do in mammals. Here we show that
zebraﬁsh syk and zap-70 play unexpected and redundant roles to
promote the migration of angioblasts to form both blood vascular and
lymphatic vascular systems.
Materials and methods
Zebraﬁsh husbandry
Embryos were raised at 28.5 °C in E3 embryo media (5 mM NaCl,
0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4) supplemented with
0.25 mg/l methylene blue, and staged by hours post fertilization (hpf)
or days post fertilization (dpf) according to Kimmel et al. (1995).
Chorions were removed by incubation in 20 mg/ml pronase (Sigma, St.
Louis, MO) and pigmentation was blocked at 24 hpf by the addition of
0.003% 1-phenyl-2-thiourea (Sigma). Tg(ﬂi1a:egfp)y1 (Lawson and
Weinstein, 2002), Tg(ﬂi1a:nEGFP)y7 (Roman et al., 2002) or Tg(kdr-1:
GFP)la116 (Choi et al., 2007) embryos on a wild-type Tupfel long ﬁn (TL)
background were used for all experiments.
Identiﬁcation, phylogenetic, and structural analysis of the zebraﬁsh syk
and zap-70 orthologs
The full length zebraﬁsh (Danio rerio) syk ortholog has previously
been identiﬁed: AF253046 or ZFIN:ZDB-GENE-040702-3. The full length
D. rerio zap-70 ortholog is zgc:110383 (ZFIN:ZDB-GENE-050522-257).
Nucleotide sequences of D. rerio syk (NP_998008.1), Homo sapiens SYK
(NP_003168.2),Musmusculus SYK (NP_035648.2), Tetraodon nigroviridis
Syk (CAF96564), Gallus gallus Syk (NP_001026601), Xenopus tropicalis
Syk (NP_001086665), Takifugu rubripes Syk (SINFRUG00000143646),
D. rerio zap-70 (NP_001018425.1), H. sapiens ZAP-70 (NP_001070),
M.musculus ZAP-70 (NP_033565.2), T. nigroviridis Zap-70 (CAG00734.1),
G. gallus Zap-70 (NP_001026601.1), and T. rubripes Zap-70 (SIN-
FRUG00000148610)were analyzedwith theCLUSTALW(1.81)multiple
sequence alignment program.
Morpholino injection and angiography
The following splice site targeted morpholinos were synthesized by
GeneTools LLC (Philomath, OR): syke2i2 5′-AGTGAAGAAGACTTACAGAA-
ATTTG-3′; syke7i7 5′-TGAAGCACACCAACCTGAATCCAAG-3′; zap-70i1e2
5′-TGGCATCCCCCTAAAAAGGTAACAA-3′; zap-70e3i3 5′-TTGATGGG-
CAAAACGTACCTGCCAC-3′; vegfa3 5′-TAAGAAAGCGAAGCTGCTG-
GGTATG-3′ (Nasevicius et al., 2000). Morpholino efﬁciency was
conﬁrmed by reverse transcriptase polymerase chain reaction (RT-
PCR) with gene speciﬁc primers over the morpholino target site
(Supplementary Fig. 1). All primer sequences are listed in Supplemen-
tary Table 1. Equal loading of products was conﬁrmed by RT-PCR with
primers speciﬁc to elongation factor 1α (eF1αF/eF1αR, Supplementary
Fig. 1). Off-target effects of morpholinos were assayed by incubation of
live embryos in 5 μg/ml acridine orange (Sigma) for 30 min at 28 °C.Blood ﬂow in wild-type and morphant embryos was assessed by
angiography through the injection of 2 MDa rhodamine dextran
(Molecular Probes, Carlsbad, CA) into the sinus venosus of 5 dpf
embryos. For ﬂuorescent images embryosweremounted in 3%methyl
cellulose (Sigma, St. Louis, MO), and photographed with a Stemi SV 11
microscope and an AxioCam HRc camera with AxioVision software
(Carl Zeiss Canada Ltd., Toronto, ON). Confocal images were obtained
by embedding embryos in 1.2% agarose, and photographed with an
Olympus FV5-PSU. Some images taken at high resolution were pieced
together with Adobe Photoshop.Probe synthesis and whole-mount in situ hybridization
syk and zap-70 probe templates were ampliﬁed from adult
zebraﬁsh ﬁn cDNA with gene speciﬁc primers sykF/T7sykR and zap-
70F/T7zap-70R (Supplementary Table 1). Products were puriﬁed with
the QIAGEN PCR puriﬁcation kit (QIAGEN, Mississauga, ON) prior to
transcribing with T7 RNA polymerase (Invitrogen, Burlington, ON).
Whole-mount in situ hybridization was performed on embryos as
previously described (Oxtoby and Jowett, 1993). All post hybridization
washeswere performedwith the aid of the BioLane™HTI Robot (Holle
and Huttner, Tübingen, Germany). The embryos were developed in
BCIP/NBT at room temperature for 5–7 days (Roche Applied Science,
Lavalle, QC). Whole-mount images were captured as above. A second
set of full length antisense probeswere also created against the syk and
zap-70 genes and resulted in the same expression patterns (data not
shown).Genetic rescue with gata1:syk and ﬂi:syk
Multisite Gateway® cloning (Invitrogen), as developed by Kwan
et al. (2007), was used to create full length, C-terminal myc-tagged
transcripts of zebraﬁsh syk under the control of a blood-expressed
gata1 promoter (Long et al., 1997) and endothelial-cell expressed
ﬂi1 promoter (Buchner et al., 2007). Full length syk was ampliﬁed
from wild-type cDNA with primers incorporating a portion of the
attB1 and attB2 recombination sites required for Gateway cloning
(sykFB1/sykRB2, Supplementary Table 1). A second round of PCR was
performed to incorporate the entire attB1 and attB2 recombination
sites, prior to Gateway cloning into the entry vector pDONOR221 with
BP Clonase (Invitrogen). Thesemiddle entry constructs, plus a 5′ entry
clone with either 5.4 kb of the gata1 promoter (Long et al., 1997) or
2 kb of the ﬂi1 promoter (Buchner et al., 2007), and a 3′ entry clone
with 6× C-terminal myc tag fusion and SV40 late polyA (p3E-MTpA),
were combined with the multisite destination vector pDestTol2pA2
(Invitrogen) to obtain gata1:syk and ﬂi1:syk. For rescue experiments,
50 pg of transposase and 10 pg of DNA were co-injected into single
cell embryos.Whole-mount immunohistochemistry
Embryoswereﬁxed in 4% paraformaldehyde in phosphate buffered
saline (PBS) for 2 h at room temperature, permeabilized in methanol
for 30 min at 4 °C, and then blocked in 10% normal sheep serum (NSS)
in PBSwith the addition of 0.1% Tween-20 (PBT). Immunostainingwas
performed overnight at 4 °C in 10% NSS/PBT with a 1:100 dilution of
αphospho-p44/42Map Kinase (Thr202/Tyr204) (αERK-P) polyclonal
antibody (Cell Signaling, Danvers, MA), or a 1:20 dilution of αcMyc-
9E10 (Developmental Studies Hybridoma Bank, Iowa City, IA).
Embryos were washed thoroughly with PBT prior to incubation with
a 1:250 dilution of goat α–rabbit Alexa555 secondary antibody
(Invitrogen) in PBT. Embryos were imaged as for whole-mount
in situ hybridization.
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Zebraﬁsh syk and zap-70 are orthologs of mammalian SYK and ZAP-70
To identify the roles of syk and zap-70 in zebraﬁsh, we ﬁrst
identiﬁed their gene sequences from the genomic database. We ﬁnd
that there is a single zebraﬁsh syk ortholog, located on chromosome
10. Likewise, there is a single zap-70 ortholog on chromosome 8. By
PCR, we identiﬁed a single transcript for syk and a single transcript for
zap-70. Mammalian SYK and ZAP-70 contain two N-terminal SH2
domains and a C-terminal tyrosine kinase domain (reviewed in
Turner et al., 2000). Similar to mammals, an NCBI Conserved Domain
Search (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi)
(Marchler-Bauer A, 2004) predicts that zebraﬁsh Syk and Zap-70
contain two C-terminal SH2 domains and an N-terminal tyrosine
kinase domain (PTK, Fig. 1A). Mammalian SYK is alternatively spliced
and the less abundant, shorter isoform of mammalian SYK is more
similar in structure to mammalian ZAP-70 (Turner et al., 2000).
Nucleotide sequence alignment of syk and zap-70 with orthologs in
other species show clear clustering of zebraﬁsh sykwith the other Syk
orthologs, and zap-70 with the other Zap-70 orthologs (Fig. 1B).
syk and zap-70 function redundantly to promote trunk angiogenesis
To assess the biological function of syk and zap-70 in zebraﬁsh
vascular development, two independent morpholino antisense oligo-
nucleotides (MOs) were targeted to block splicing of each gene.
Independently targeted morpholinos were used to conﬁrm that the
observed phenotype was due to speciﬁc downregulation of these
genes. The morpholinos were targeted to exon 2–intron 2 (e2i2) of
syk (syke2i2), e7i7 of syk (syke7i7), e3i3 of zap-70 (zap-70e3i3) and
intron 1, exon 2 of zap-70 (zap-70i1e2). Single MOs against each gene
were injected into Tg(ﬂi1a:EGFP)y1 embryos expressing GFP in all
endothelial cells, and development of the vasculature was monitored
by ﬂuorescence. Morpholino efﬁciency was conﬁrmed by RT-PCRwith
primers designed over the targeted exon–intron boundary to test for
omission of the targeted exon from the transcript (SupplementaryFig. 1. The zebraﬁsh orthologs of syk and zap-70 mediate angioblast migration to form the I
domains, and a C-terminal tyrosine kinase domain (PTK). (B) Alignment of the nucleotide
zebraﬁsh syk with the other syk orthologs, and zap-70 with the other zap-70 orthologs. (C) A
and are contributing to the DLAV in wild-type embryos. (D–E) Injection of a low dose of sykm
completely suppressed (asterisk) angioblast migration to form the ISVs. (F) Co-injection o
angioblast migration (sykLO:zap-70LO). (G–H) Tg(ﬂi1a:EGFP)y7 embryos with endothelial-exp
the left in all embryos. DA: dorsal aorta; PCV: posterior cardinal vein; ISV: intersegmental vFig. 1), and showed that all morpholinos efﬁciently inhibited splicing
of syk and zap-70 at both 30 and 48 hpf with the exception of zap-
70i1e2 which was more efﬁcient at 30 hpf than at 48 hpf. The pheno-
types were indistinguishable after injection of either of the two syk
morpholinos or two zap-70 morpholinos, suggesting speciﬁcity. At
30 hpf, ISV sprouts in control embryos have reached the dorsal aspect
of the embryo, and are joining with adjacent ISVs to form the dorsal
longitudinal anastomotic vessel (DLAV) (Fig. 1C). Control embryos
also possess a fully formed dorsal aorta (DA) and posterior cardinal
vein (PCV) at this time. Low dose injection of either morpholino
(∼1.5 ng of syke2i2 morpholino (sykLO), or ∼3.4 ng of zap-70e3i3
morpholino (zapLO)) into Tg(ﬂi1a:EGFP)y1 embryos resulted in
delayed sprouting (i.e. migration) of angioblasts to form the trunk
intersegmental vessels (ISVs) (Figs. 1D–E). In some instances, the
sprouting of individual ISVs was completely suppressed (asterisks in
Fig. 1). 89% of wild-type ISVs have reached the DLAV at 30 hpf
(n=287), while only 3% of syke2i2 (n=79), 10% of syke7i7(n=122),
9% of zap-70e3i3 (n=74), and 14% of zap-70i1e2 (n=189) morphant
ISVs have reached the DLAV (Supplementary Fig. 2). The morphology
of these morphants is shown in Supplementary Fig. 3. Co-injection
of sykLO and zap-70LO suggests syk and zap-70 function redundantly
since sykLO:zap-70LO double morphants show a similar but more
pronounced phenotype, with increased suppression of ISV sprouts
(Fig. 1F). Higher doses of zap-70e3i3 (>8 ng) resulted in a more
penetrant phenotype, while injection of doses higher than 4 ng of
syke2i2morpholino resulted in severelymalformed embryos and death
(results not shown).
Delay in migration of ISV angioblasts in sykLO:zap-70LO double
morphants may result from defects in migration or proliferation. To
assess whether loss of syk and zap-70 leads to proliferation defects, we
counted the number of angioblasts per ISV sprout in Tg(ﬂi1a:nEGFP)y7
embryos. We have previously demonstrated that a single ISV is
comprised of three to four endothelial cells with distinct fates; the
ventral stalk cell, a connector cell that runs the length of the somite
boundary, and a dorsal T-shaped cell that contributes to the DLAV
(Childs et al., 2002). These cells can be visualized in Tg(ﬂi1a:nEGFP)y7
embryos expressing GFP in the nuclei of their endothelial cellsSVs. (A) Zebraﬁsh syk and zap-70 have similar domain structures with N-terminal SH2
sequences of syk and zap-70 with orthologs in other species shows a clear grouping of
t 30 hpf, ISVs in Tg(ﬂi1a:EGFP)y1 embryos have reached the dorsal aspect of the somite
orpholino (sykLO, D) or zap-70morpholino (zap-70LO, E) results in delayed (arrows) or
f low doses of both morpholinos results in a more severe stalling and suppression of
ressed nuclear GFP show fewer cells in the ISVs of sykLO:zap-70LO embryos. Anterior is to
essel; DLAV: dorsal longitudinal anastomotic vessel; hpf: hours post fertilization.
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embryos show a median of four nuclei per ISV (n=100 ISVs; Fig. 1G)
while sykLO:zap-70LO double morphants only show a median of two
nuclei per ISV at the same developmental stage (n=100 ISVs; Fig. 1H,
Supplementary Fig. 4) suggesting the cell division andmigrationprocess
had not yet occurred. The angiogenic delay is not likely due to altered
trunk architecture as sykLO:zap-70LO morphants with delayed vessels
displayed normal somite structure as visualized by F59 fast-twitch
muscle ﬁber staining (Devoto et al., 1996) (data not shown). We also
observed that the number of cells in the trunk axial vessels (dorsal aorta
and posterior cardinal vein) was reduced. An average of 95 endothelial
cells was observed in the axial vessels between a region under 10
somites in wild-type embryos (n=50 ISVs) while an average of 71 cells
was observed in the equivalent region in sykLO:zap-70LO morphants
(n=70 ISVs; Supplementary Fig. 5). Acridine orange staining was used
as a marker of cell death and to observe possible off-target effects. A
small increase in cell death was observed although it did not appear to
be localized to vessels (Supplementary Fig. 6). Surprisingly by 48 hpf,
morphants showed some recovery to form full ISVs and the DLAV,
although the morphology of the vessels was abnormal (data not
shown). Since it is only angiogenesis that was delayed and not the
overall growth of the embryo, and since themorpholinos still effectively
inhibited splicing of syk and zap-70 at this timepoint, this suggests that
while syk and zap-70 function in the initial migration of angioblasts
from the artery, a second pathway promoting angioblast migration
drives the angioblasts to their correct ﬁnal position.Fig. 2. sykLO and zap-70LO morphants display late stage ISV patterning defects. (A) The trunk
somites, with the dorsal-most ISV endothelial cell forming a clear T shape and contributing t
display abnormal ISV vasculature with mild patterning defects. The ventral stalk ISV endo
the branching of the cell into the T shape is abnormal (asterisks) and can occur as ventrall
sykLO:zap-70LO morphants.sykLO and zap-70LO morphants display late stage dorsal vascular
patterning defects
At 5 dpf, wild-type Tg(ﬂi1a:EGFP)y1 embryos show regularly
patterned ISVs between somites (Fig. 2A). The dorsal-most endothelial
cell in the ISV forms a clear T shape, contributing to theDLAV. There is a
clear distinction between the dorsal aorta and posterior cardinal vein.
The main lymphatic vessel, the thoracic duct (TD), is visible between
the dorsal aorta and posterior cardinal vein. In contrast, at 5 dpf, sykLO,
zap-70LO, and sykLO:zap-70LO double morphants have pericardial and
general body edema (data not shown). Few embryos survive to 5 dpf
and maintain circulation, but in those embryos with circulation we
found that the ISVs appear abnormal and have mild dorsal patterning
defects (asterisks, arrows, Figs. 2B–D). Although the dorsal T-cell still
contributed to the DLAV, branching of the cell into the T shape was
abnormal, and sometimes occurred midsomite. These defects resulted
in a misshapen DLAV in morphants. Not surprisingly, the dorsal
patterning defects were more pronounced in the sykLO:zap-70LO
double morphants (Fig. 2D). The vertebral artery and parachordal
lymphangioblasts appeared normal in the morphants.
Since SYK has been implicated in the development of the
mammalian lymphatic system, 5 dpf morphants with a strong heart
beat and circulation were analyzed for the presence of a thoracic duct
by injection of 2 MDa rhodamine dextran into the vascular, but not
lymphatic, circulation via the sinus venosus. Angiography depends on
blood ﬂow and can only be performed on embryos with robustof 5 dpf wild-type Tg(ﬂi1a:EGFP)y1 embryos display regularly patterned ISVs between
o the DLAV. In contrast, 5 dpf sykLO (B), zap-70LO (C), and sykLO:zap-70LO (D) morphants
thelial cell is relatively normal, and the dorsal T-cell still contributes to the DLAV, but
y as midsomite (arrows). These dorsal patterning defects are more pronounced in the
Fig. 3. sykHI:zap-70HI morphants resemble vegfa morphants and lack activated ERK.
(A) sykHI:zap-70HI Tg(ﬂi1a:EGFP)y1morphants have a complete suppression of ISV
sprouting which is phenotypically similar to the ISV stalling observed in high dose vegfa
morphants (B). While the artery of 20s wildtype (WT) embryos (arrow, C’) shows
activated ERK (arrow, C”) comparable staged sykHI:zap-70HI morphants (D) show a
strong downregulation of activated ERK (arrow D’=artery, D”). The level of down-
regulation of activated ERK in the artery (arrow, E’) is similar to vegfaHI morphants
(E, E”). C’, D’, E’ are enlargements of GFP signal in the boxed region of C, D, E, respectively.
C”, D”, E” are enlargements of the αERK-P immunohistochemistry in the boxed regions
of C, D, and E respectively.
Fig. 4. syk rescues angioblast migration defects after syk knockdown. (A–D) syk and
zap-70 are expressed in a ubiquitousmanner and have overlapping expression proﬁles. At
16 somites (16s) syk (A) and zap-70 (C) are highly expressed in the head,with low levels of
expression throughout the rest of the embryo. (B, D) By 21s increased expression is seen
in the ventral trunk. (E–F) By 30 hpf, the ISVs of wildtype Tg(ﬂi1:egfp)y1 embryos have
reached the dorsal portion of the embryo to form the DLAV (E) while the ISVs of syk
morphants are delayed at themid-trunk (F). (G–H)Expression of a C-terminalmyc-tagged
syk in the vasculature (G, ﬂi1:syk:myc) or blood (H, gata1:syk:myc) partially rescues the
number of ISVs that have reached the DLAV (black arrow).
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showed a clear separation between the dorsal aorta and posterior
cardinal vein, and the presence of the thoracic duct lacking dye
between the two vessels, while angiography in sykLO, zap-70LO, and
sykLO:zap-70LO double morphants demonstrated the clear lack of a
thoracic duct between the artery and vein (Supplementary Fig. 7).
syk functions downstream of vegfa to mediate vascular growth
To observe the effect of redundancy between syk and zap-70, we
co-injected higher doses of syke2i2 and zap-70e3i3 morpholino
(∼2.5 ng and ∼4.5 ng respectively). sykHI:zap-70HI double morphants
had a nearly complete knockdown of both genes resulting in a severe
vascular phenotype with a complete lack of ISV angioblast migration
from the aorta (Fig. 3A). sykHI:zap-70HI double morphants did not
survive past 2 dpf. This severe effect is reminiscent of the lack ofsprouting observed in vegfa morphants (Nasevicius et al., 2000)
after injection of 4 ng of morpholino targeted against vegfa (vegfaHI,
Fig. 3B). vegfa, signaling through PLCγ1 and ERK, has been previously
shown to be critical for arterial ISV growth and speciﬁcation (Hong
et al., 2006). As both syk and zap-70 can phosphorylate PLCγ1 (Law
et al., 1996; Williams et al., 1999), and alterations in syk and zap-70
in vitro can affect levels of phosphorylated ERK (Grifﬁth et al., 1998;
Parsa et al., 2008; Shan et al., 2001; Slack et al., 2007) we investigated
whether syk inﬂuences ISV growth through a pathway involving vegfa.
Compared towildtype embryos (Fig. 3C, C’, C”) di-phosphorylated ERK
was strongly downregulated in the dorsal aorta of sykHI:zap-70HI
double morphants (Fig. 3D, D’, D”), similar to what is seen in vegfaHI
morphants (Fig. 3E, E’, E”).
The phenotypic similarity of the sykHI:zap-70HI double morphants
to vegfaHImorphants leads us to investigate if the lack of ISV sprouting
observed in vegfa morphants could be rescued by over-expression of
syk. In wild-type embryos syk and zap-70 are co-expressed and are
ubiquitous (Figs. 4A–D). At 16 somites (s) syk and zap-70 are highly
expressed in the head, with low levels of expression throughout
the rest of the embryo (Figs. 4A, C). This pattern of expression con-
tinues through to 21s when the signal increases in the ventral trunk
(Figs. 4B, D). syk and zap-70 are thus expressed at the proper time to
interact with the VEGF pathway in sprouting angiogenesis.
To determine whether syk is required in the blood and/or endo-
thelial cells for vascular growth, we used the gata1 promoter (blood)
or the ﬂi1 promoter (endothelium) to drive expression of a C-terminal
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changeable in previous studies (Fallah-Arani et al., 2008; Gong
et al., 1997), we used syk in this rescue. After injection of ﬂi1:syk or
gata1:syk into syk morphants we observed a statistically signiﬁcant
increase in the number of ISVs that reached the DLAV in comparison
to syk morphants (Figs. 4. E–H, Supplementary Table 2 and 3 respec-
tively), suggesting that the speciﬁc lack of syk in an endothelial or
blood population causes defects in syk morphants. As DNA injections
are mosaic and cell autonomous, the rescued cells are seen as single
cells in the DLAV without necessarily being connected to the full ISV.
We next set out to rescue vegfa morphants using the same con-
structs with the hypothesis that expression of syk in either tissue
could rescue the vegfa morphant phenotype. We found that injection
of ﬂi1:syk or gata1:syk into vegfa morphants resulted in a signiﬁcant
increase in the number of endothelial cells that reached the DLAV
(p=0.004 or p<0.001 respectively, Fig. 5; Supplementary Tables 4
and 5). Myc staining of the injected protein demonstrated that syk
expressed under the ﬂi1a promoter was clearly visible in rescued ISV
cells (Fig. 5C), while myc was not detectable in ISV cells in gata1:syk
injected embryos (Fig. 5D). This could reﬂect the different timings of
expression of each promoter where the transgene is no longer
expressed at this timepoint in gata1:syk embryos, or an indirect effectFig. 5. Endothelial and vascular expression of syk rescues angioblasts migration in vegfa
morphants. (A–B) Compared to 30 hpf wildtype Tg(ﬂi1:egfp)y1 embryos with complete
ISVs (A), vegfamorphants lack any ISV sprouting (B). (C–D) Expression of a C-terminal
tagged syk under the control of a vascular ﬂi1 promoter (ﬂi1:syk:myc, C) or a blood
gata1 promoter (gata1:syk:myc, D) in single celled embryos injected with 4 ng of
vegfa morpholino results in increased number of ISV sprouting (white arrow).
Expression of the ﬂi1:syk:myc construct is detected by immunohistochemistry against
the myc tag (red, C, D). The large myc-expressing cells visible in the dorsal and mid-
trunk of gata:syk injected embryos are superﬁcial and do not represent expression of
the transgene in blood vessels, while ventral myc expression cells are within the axial
vessels.in promoting sprouting by gata1:syk (i.e. a blood cell or EPC paracrine
effect on angioblasts) since expression is still observed in the dorsal
aorta. The signiﬁcant rescue of angioblast migration after loss of vegfa
suggests syk functions in blood to effect vascular migration down-
stream of, or in a parallel pathway, to vegfa. Increased expression of
syk in blood and endothelial cells has no effect on the growth of the
ISVs in wild-type embryos (data not shown).
Discussion
The zebraﬁsh is a powerful model system to identify genes affecting
vessel growth since the vessels of the trunk contain few angioblasts and
develop in a characteristic manner. Several genes have been identiﬁed
to play roles in ISVmigration, including vegfa and its receptors (Covassin
et al., 2006), and downstream components of the pathway such as PLCγ
(Lawson et al., 2003). We show a genetic interaction between syk and
the vegfa pathway through rescue of vegfa morphants with over-
expression of syk in blood and endothelial cells. In vitro, Syk has been
shown to play an important role in endothelial-cell proliferation and
migration in HUVEC cells in response to bFGF and VEGF (Inatome et al.,
2001). A kinase dead Sykmutant results in decreased cell proliferation,
survival, and migration, while over-expression of Syk results in
increased levels of activated ERK (Inatome et al., 2001). Ours is the
ﬁrst in vivo evidence of syk affecting the migration of angioblasts, and
the ﬁrst evidence that zap-70 plays a similar role.
Although downregulation of syk and zap-70 results in a strong
phenotype at 30 hpf, this phenotype resolves itself by 48 hpf, similar
to resolution in low dose vegfa morphants, and plcγ1y10 mutants
(Yaniv et al., 2006) which also recover from initially stalled ISV
growth. This could result from genetic redundancy resulting from
expression of unknown genes which compensate for the loss of syk
and/or zap-70.
Here we show that syk and zap-70 function redundantly in
zebraﬁsh to regulate angioblast migration to form the ISVs. After the
ISVs ﬁnally ﬁnish growing in the low dose morphants, dorsal
patterning defects still result. This is a common phenotype among
embryos with delayed ISV sprouting and may reﬂect that delayed
sprouting prevents angioblasts from receiving the necessary signals
for late stage angiogenic patterning.
Similarly, taking into account the manner in which the zebraﬁsh
thoracic duct develops, angiogenic delay may also explain the dif-
ferences in lymphatic vessel phenotypes between zebraﬁsh syk
morphants and Syk null mice. Syk null mice present with superﬁcial
vascular malformations resulting from the improper partitioning of
the developing lymphatic system (Abtahian et al., 2003). In mammals,
the main lymphatic thoracic duct develops directly off of the cardinal
vein (Wigle et al., 2002). Syk and its substrate Slp-76 are involved in
the process that segregates these two vascular systems (Abtahian
et al., 2003; Sebzda et al., 2006). If the blood and lymphatic system do
not segregate properly, the blood will be free to enter the lymphatic
system, resulting in blood-ﬁlled lymphatics. In zebraﬁsh the main
lymphatic thoracic duct does not directly bud off of the venous
system, but instead develops by the de novo migration of individual
cells which originate from the main venous axial vessel (Hogan et al.,
2009; Yaniv et al., 2006) These cells migrate to their ﬁnal location
between the dorsal aorta and posterior cardinal vein to form the
functional thoracic duct. In zebraﬁsh syk and/or zap morphants, the
thoracic duct is partially or completely missing. Although this might
indicate that syk and zap-70 play roles in both blood and lymphatic
vascular patterning in the zebraﬁsh, we suggest that the delay in
angiogenesis of the blood vascular system results in a lack of forma-
tion of lymphatic vessels. For instance, if precursors are not in the
correct position at the right time they may fail to receive the proper
signals for their subsequent differentiation and migration.
Since knockdown of both vegfa and syk/zap-70 affect ISV arterial
angiogenesis, we hypothesized that syk and zap-70 might function
28 T.L. Christie et al. / Developmental Biology 340 (2010) 22–29redundantly through a vegfa/ERK pathway. We found there was a
downregulation of activated ERK in sykHI:zapHI double morphants,
and we were able to rescue the vegfa morphant phenotype by over-
expression of sykunder the control of a blood or endothelial-expressed
promoter. These results are consistent with previous studies in mice
that show Syk functions in endothelial precursor cells during the
separation of the blood and lymphatic vasculature (Sebzda et al.,
2006). The vegfa pathway is a key regulator of ISV migration and
arterial speciﬁcation that signals through the receptors Vegfr1/2 to
activate PI3K, or PLCγ1 and ERK (Hong et al., 2006; Lawson et al.,
2003). In addition, recent data shows that PLCγ2 is also necessary for
lymphatic separation from the blood vasculature as mouse mutants
display blood-ﬁlled lymphatics (Ichise et al., 2009). Both Syk and Zap-
70 can phosphorylate PLCγ1 (Law et al., 1996; Williams et al., 1999)
and activate ERK (Grifﬁth et al., 1998; Parsa et al., 2008; Shan et al.,
2001; Slack et al., 2007) in vitro. Although we ﬁnd changes in ERK
phosphorylation, we did not ﬁnd any defects in markers of arterial–
venous identity in syk/zap-70 double morphants (data not shown).
ERK is important in arterial identity of zebraﬁsh ISVs (Hong et al.,
2006), but has also been shown to regulate cell migration through
direct activation ofmyosin light chain kinase (Klemke et al., 1997). Our
results suggest syk and zap-70 activate the ERK pathway that regulates
cell migration, but not cell identity.
Mammalian Syk was ﬁrst characterized as an abundant protein
tyrosine kinase in thymus and spleen (reviewed in Turner et al.,
2000). Though Syk has mostly been studied in hematopoietic tissues
such as fetal liver cells and human platelets, Syk is also found at low
levels in nonhematopoietic cells including endothelial cells, hepa-
tocytes, neuronal cells, breast tissue and ﬁbroblasts. We ﬁnd that
both syk and zap-70 are ubiquitously expressed throughout the
zebraﬁsh. Interestingly, although ubiquitously expressed, down-
regulation of syk and/or zap-70 results in speciﬁc vascular defects.
Syk has been detected in endothelial cells in vivo, HUVECs, BAECs
and endothelial precursor cells (Furuhata et al., 2007; Inatome et al.,
2001; Sebzda et al., 2006; Yanagi et al., 2001). Recent studies show
syk likely functions in circulating endothelial precursor cells which
contribute to lymphatic development. EPCs have not been charac-
terized in zebraﬁsh, but our rescue data suggests that autonomous
expression of syk in blood (a source of EPCs) is sufﬁcient to
promote angioblast migration. Yanagi et al. (2001), have noted that
Syk-deﬁcient mice have decreased numbers of endothelial cells and
abnormal morphology (similar to the phenotype we identify in syk
or syk:zap-70 knockdown zebraﬁsh embryos), but did not suggest a
mechanism. Autocrine signaling of VEGF in endothelial cells has also
been shown to be critical for promoting the survival of endothelial
cells (Lee et al., 2007). Whether syk and/or zap-70 function directly
in a VEGF pathway, or indirectly by inﬂuencing ERK or other
downstream signaling molecules such as PLCγ will be interesting to
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